Inhaled medicine specialist Vectura is set to be bought by private equity giant Carlyle after the firm agreed a £958m buyout of the UK business.
Carlyle agrees £958m take-private of inhaled medicine specialist Vectura first appeared on AltAssets Private Equity News.